Join us this episode as we talk with Artera, a company leading in the AI space with personalised prognostic insights in cancer care. We learn about this fascinating development of AI in digital pathology which can be rolled out across demographics with predictive applications in prostate and other cancer streams.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör NSW Early Phase Clinical Trials Alliance (NECTA). Innehållet i podden är skapat av NSW Early Phase Clinical Trials Alliance (NECTA) och inte av, eller tillsammans med, Poddtoppen.